Preclinical data suggests we, at Openwater, can destroy glioblastoma cancer cells 5x better than chemotherapy with no damage to the healthy brain tissue. This could be a game changer for all aggressive cancers in that we exploit a mechanical property common to fast growing cancers. Using the same basic hardware with a different software layer we are quelling over-firing neurons in humans via depression studies where we can see the results on MRI scans and correlate to the self-reported lowering of depression. Dr. Mary Lou Jepsen will discuss these programs, the technical details and the implications for good health care for all.
1 p.m. – 2 p.m. ET
Virtual on Zoom
Part of the NanoBio Seminar Series.